Skip to main content

REPROCELL Corporate News (4)

REPROCELL Corporate News

Glasgow, UK: REPROCELL (Biopta) today announced the successful publication of a novel study in pharmacology and genomics to improve strategies for the development of precision medicines. The study –...

Lantern Pharma a clinical stage oncology biotech leveraging A.I. and machine learning genomics company has selected REPROCELL Inc. to provide drug screening and drug sensitivity services. BELTSVILLE,...

The REPROCELL group has signed a non-exclusive distributorship agreement with A.N.H. Scientific Marketing Co. Ltd. to distribute REPROCELL’s products and services in Thailand. For more than 35 years,...

Maryland, September 2019: The Maryland based REPROCELL Inc. subsidiary, REPROCELL USA Inc. announces that they have received a $292,580 grant from the Maryland Stem Cell Research Fund (MSCRF)....

Yokohama, Japan, & San Carlos, California, USA — REPROCELL, Inc., and NeuCyte, Inc., today announced a new distributorship. Although NeuCyte has direct sales in North America, this new...

Axion BioSystems, Inc., the world leader in multi-well microelectrode array (MEA) systems, has announced REPROCELL as the new distributor of its Maestro systems and consumables in Japan. Maestro Pro...

The lab-scale system will allow researchers to study and culture stem cells in suspension Glasgow, UK: REPROCELL Europe Ltd today announced exclusive distribution rights to a single-use reactor...

Yokohama Japan – REPROCELL Inc. today announced that it has established the current good manufacturing practice (cGMP) cell processing suite at Life Innovation Center (LIC) in Tonomachi area in...

REPROCELL India (formerly BioServe Biotechnologies India Pvt Ltd) and Hanugen Therapeutics have announced the launch of their custom manufacture offering for synthesis of milli molar scale clinical...

See the press release on PRWeb: REPROCELL USA Inc. Achieves Quality Management ISO9001:2015 Certification REPROCELL USA has achieved ISO9001:2015 accreditation for quality management utilizing the...

The return on R&D investments in the UK is at its lowest rate in nine years, despite Britain’s global presence in science, technology and health. Pharmaceutical attrition rates continue to rise, and...

Wave 3 of the UK Government’s science and innovation audits (SIAs) have been published today, identifying a number of strengths in different industries across the country — including precision...

The collaboration is part of Medicines Discovery Catapult’s Virtual R&D network, which aims to support UK SMEs develop and execute their drug discovery projects with industrial rigour. The...

BELTSVILLE, MD. — REPROCELL Inc. and Fox Chase, Ltd., a member of the Fox Chase Cancer Center family of organizations, have formed a joint venture to begin operations of multi-site biosample...

The REPROCELL group has signed a non-exclusive distributorship agreement with RUITAI Biotechnology (Shanghai) Ltd to distribute REPROCELL’s products in China. Through the RUITAI group’s offices in...

If you are a science student nearing the end of your university program, developing your professional network in order to land a good job is a daunting task. In this video, Zara Puckrin and Karen...

Funding will be used to improve efficiency of induced pluripotent stem cell production Edinburgh, UK and Glasgow, UK: ROSLINCT, a leading cell and gene therapy contract manufacturing organisation,...

REPROCELL announced today we have launched a cutting-edge genome editing service utilizing next-generation CRISPR/Cas9 technology, called SNIPER. This service is offered in collaboration with...

How can industry inspire the next generation of life science professionals? In this post, summer intern Zara Puckrin describes the challenges faced by today’s graduates and explains how REPROCELL...

San Diego, CA, USA – Steminent Biotherapeutics Inc. (“Steminent” or “Company”) a private, clinical-stage cell-therapy company with offices in Taiwan, San Diego and Shanghai, is pleased to announce...